In this episode, we dive into the potential of liquid biopsies as a method to detect deadly diseases. We speak with three experts – Marta Herreros, Rik Bryan, and Doug Ward – to learn more about the non-invasive nature of liquid biopsies and the process of detecting biomarkers within a patient sample. Rik and Doug discuss their GALEAS Bladder test, which can identify key mutations present in 96% of bladder cancer patients. Tune in to learn more about the potential of liquid biopsies and the importance of early detection!
Show notes
- GALEAS Bladder test – Galeas Bladder
- BBC and hybrid working – Internal Communications Europe 2023 — BBC
- Identification by ears – Ear identification: A multi-ethnic study sample - ScienceDirect
Keywords: bladder cancer, patient, liquid biopsy, urine, cells, bladder, urine test, urine sample, mutations, tumor, DNA, cancer, clinical trials, sequencing, samples, biomarkers.
Fler avsnitt av Discovery Matters
Visa alla avsnitt av Discovery MattersDiscovery Matters med Discovery Matters finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
